We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£149.65
Springer TOR: Target of Rapamycin: 279 (Current Topics in Microbiology and Immunology, 279)
Price data last checked 11 day(s) ago - will refresh soon
Price History & Forecast
Last 80 days • 80 data points (No recent data available)
Price Distribution
Price distribution over 80 days • 1 price levels
Price Analysis
Most common price: £149 (80 days, 100.0%)
Price range: £149 - £149
Price levels: 1 different prices over 80 days
Description
Product Description TOR, the Target of Rapamycin was discovered a little over ten years ago in a genetic screen in S. cerevisiae in search of mutants resistant to the cytostatic effects of the antimycotic, rapamycin. Recent studies have placed TOR at the interface between nutrient sensing and the regulation of major anbolic and catabolic responses. The editors have gathered the leading figures in the field of TOR and its role in cellular homeostasis and human diseases. From the Back Cover TOR, the Target of Rapamycin was discovered a little over ten years ago in a genetic screen in S. cerevisiae in search of mutants resistant to the cytostatic effects of the anti-mycotic, rapamycin. Since that time orthologues have been identified in all eukaryotes examined to date, including humans. Recent studies have placed TOR at the interface between nutrient sensing and the regulation of major anabolic and catabolic responses. The significance of understanding the molecular mechanisms which control TOR function has been underscored by Phase 1 clinical trials, showing that rapamycin is not only therapeutically important as an immunosuppressive but is also efficacious in the treatment of solid tumors. Indeed, currently, homologues of rapamycin are in broad-based trials to determine its use in the treatment of other pathological conditions, such as inflammation and restenosis. Given these observations a great deal of attention has been drawn to TOR and its role cellular homoeostasis and human disease. Here we have gathered the leading figures in the field to summarize their own contributions to uncovering TOR function and to speculate where they think the field will be moving in the next few years.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 3642623603
- Domain
- Amazon UK
- Publication Date
- 21 October 2012
- Listed Since
- 20 September 2013
Barcode
No barcode data available
Similar Products You Might Like
98% match
TOR: Target of Rapamycin: 279 (Current Topics in Microbiology and Immunology, 279)
Springer
£145.51
09 Dec 2025
92% match
The Myc/Max/Mad Transcription Factor Network: 302 (Current Topics in Microbiology and Immunology, 302)
Springer
£107.32
11 Jan 2026
92% match
Negative Co-Receptors and Ligands: 350 (Current Topics in Microbiology and Immunology, 350)
Springer
£96.02
09 Mar 2026
92% match
Recent Advances on Model Hosts: 710 (Advances in Experimental Medicine and Biology, 710)
Springer
£116.17
09 Mar 2026
92% match
Recent Advances on Model Hosts: 710 (Advances in Experimental Medicine and Biology, 710)
Springer
£95.62
08 Mar 2026
92% match
Advances in Host-Directed Therapies Against Tuberculosis
Springer
£99.90
28 Jan 2026
92% match
CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential: 293 (Current Topics in Microbiology and Immunology, 293)
Springer
£135.33
12 Jan 2026
92% match
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
£129.22
04 Mar 2026
92% match
Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, Volume 1 (Infectious Disease)
Humana
£193.64
13 Dec 2025
92% match
Three Dimensional Human Organotypic Models for Biomedical Research: 430 (Current Topics in Microbiology and Immunology, 430)
Springer
£105.38
05 Apr 2026
92% match
Metabolic Interaction in Infection: 109 (Experientia Supplementum, 109)
Springer
£91.40
27 Feb 2026
92% match
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
Springer
£119.08
18 Apr 2026
92% match
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
Springer
£126.23
08 Feb 2026
92% match
Springer Complement Therapeutics: 735 - Medical Research Book
Springer
£111.14
01 Mar 2026
92% match
Immunomodulators and Combinatorial Approaches to Tackle Klebsiella
£66.72
05 Mar 2026
92% match
Bacterial Physiology: A Molecular Approach
Springer
£149.52
10 Feb 2026
92% match
C-Type Lectins in Immune Homeostasis: 429 (Current Topics in Microbiology and Immunology, 429)
£120.04
13 Jan 2026
92% match
TAM Receptors in Health and Disease: Volume 357 (International Review of Cell and Molecular Biology, Volume 357)
Academic Press
£148.98
22 Jan 2026
92% match
Springer Inflammasome Signaling and Bacterial Infections 397
Springer
£112.79
20 Apr 2026
92% match
Tumor Suppressor Genes: Volume 2: Regulation, Function, and Medicinal Applications: 223 (Methods in Molecular Biology, 223)
Humana
£81.28
23 Feb 2026
91% match
Nucleic Acid Sensors and Antiviral Immunity (Molecular Biology Intelligence Unit)
CRC Press
£174.99
12 Jan 2026
91% match
From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)
Springer
£149.65
30 Mar 2026
91% match
CD4+CD25+ Regulatory T Cells: Origin, Function and Therapeutic Potential: 293 (Current Topics in Microbiology and Immunology, 293)
Springer
£144.17
12 Jan 2026
91% match
Stress Response Pathways in Cancer: From Molecular Targets to Novel Therapeutics
Springer
£107.67
07 Jan 2026